-
Biologics: Targets & Therapy
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Biologics: Targets & Therapy
(407,277) Views
Editor in Chief Professor Doris Mangiaracina Benbrook
1177-5475
Therapeutic options in the management of acromegaly: focus on lanreotide Autogel®Ferdinand Roelfsema, Nienke R Biermasz, Alberto M Pereira, Johannes A Romijn
Randomized phase II clinical trial of chemo-immunotherapy in advanced nonsmall cell lung cancer
Eduardo Lasalvia-Prisco, Emilio Garcia-Giralt, Jesús Vázquez, Marta Aghazarian, Eduardo Lasalvia-Galante, et al
Lepirudin in the management of patients with heparin-induced thrombocytopenia
Sirak Petros
Emerging hematological targets and therapy for cardiovascular disease: From bench to bedside
Ana Villegas, Fernando A Gonzalez, Leopoldo Llorente, Santiago Redondo
Analysis and variability of TGFβ measurements in cancer patients with skeletal metastases
Peter J O’Brien, Rajeev Ramanathan, Jonathan M Yingling, Jose Baselga, Mace L Rothenberg, et al
The role of B cells in systemic sclerosis
Marina D Kraaij, Jacob M van Laar
Tipifarnib in the treatment of newly diagnosed acute myelogenous leukemia
Judith E Karp, Jeffrey E Lancet
Top-down or bottom-up: Contrasting perspectives on psychiatric diagnoses
Willem MA Verhoeven, Siegfried Tuinier, Ineke van der Burgt
Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells
Satya Prakash, Aleksandra Malgorzata Urbanska
Infliximab in ulcerative colitis
Avi Levin, Oren Shibolet
Novel targets for immunotherapy in glomerulonephritis
Mary H Foster
Advances in the treatment of monoclonal gammopaties: The emerging role of targeted therapy in plasma cell dyscrasias
Aldo M Roccaro, Irene M Ghobrial, Simona Blotta, Steven P Treon, Michele Malagola, et al
The antidiabetic effects of a dry powder of dietary vegetable and fruit mixtures in diabetic db/db mice
Chung-Man Yeung, Yi Tan, Sidney Tam, Liwei Lu, King-Hung Ko, et al
Targeted therapies in the management of renal cell carcinoma: role of bevacizumab
Bernard Escudier, Jan Cosaert, Sangeeta Jethwa
T20QoL: an observational multicenter cohort study to evaluate the quality of life in HIV-patients treated with enfuvirtide (ENF, T-20) in combination with an optimized background therapy
R Bucciardini, M Massella, A Corpolongo, P Narciso, V Fragola, et al
Ixabepilone: a new chemotherapeutic option for refractory metastatic breast cancer
Shannon Puhalla, Adam Brufsky
Functional and gene expression analysis of hTERT overexpressed endothelial cells
Haruna Takano, Satoshi Murasawa, Takayuki Asahara
IgG from patients with systemic sclerosis bind to DNA antitopoisomerase 1 in normal human fibroblasts extracts
Mathieu C Tamby, Amélie Servettaz, Nicolas Tamas, Joseph Reinbolt, Frédéric Caux, et al
New treatment options in the management of IBD – focus on colony stimulating factors
Josué Barahona-Garrido, Jesús K Yamamoto-Furusho
Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants
Asunción Mejías, Octavio Ramilo
Renal and vascular benefits of C-peptide: Molecular mechanisms of C-peptide action
Lina Nordquist, Fredrik Palm, Bradley T Andresen
Recombinant human bone morphogenetic protein-2 in the treatment of bone fractures
Neil Ghodadra, Kern Singh
Evolving therapies in the treatment of hepatocellular carcinoma
Hans Christian Spangenberg, Robert Thimme, Hubert E Blum
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- Journal Indexing
See where all the Dove Press journals are indexed




